A long look at short prokaryotic Argonautes.

abortive infection host defense prokaryotic Argonaute (pAgo) prokaryotic immunity short pAgo

Journal

Trends in cell biology
ISSN: 1879-3088
Titre abrégé: Trends Cell Biol
Pays: England
ID NLM: 9200566

Informations de publication

Date de publication:
Jul 2023
Historique:
received: 05 09 2022
revised: 23 10 2022
accepted: 31 10 2022
medline: 12 6 2023
pubmed: 26 11 2022
entrez: 25 11 2022
Statut: ppublish

Résumé

Argonaute proteins (Agos) use small 15-30 nucleotide-long guides to bind and/or cleave complementary target nucleic acids. Eukaryotic Agos mediate RNA-guided RNA silencing, while 'long' prokaryotic Agos (pAgos) use RNA or DNA guides to interfere with invading plasmid and viral DNA. Here, we review the function and mechanisms of truncated and highly divergent 'short' pAgos, which, until recently, remained functionally uncharacterized. Short pAgos have retained the Middle (MID) and P-element-Induced Wimpy Testis (PIWI) domains important for guide-mediated target binding, but lack the ability to cleave their targets. Instead, emerging insights reveal that various short pAgos interact with distinct accessory 'effector' enzymes. Upon guide-mediated detection of invading DNA by short pAgos, their associated effector enzymes kill the host cell and, consequentially, prevent spread of the invader.

Identifiants

pubmed: 36428175
pii: S0962-8924(22)00239-2
doi: 10.1016/j.tcb.2022.10.005
pii:
doi:

Substances chimiques

Argonaute Proteins 0
DNA 9007-49-2
RNA 63231-63-0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

605-618

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests D.C.S. and B.K. (together with Ana Potocnik) have submitted a patent application regarding the utilization of short pAgo systems for nucleic acid detection.

Auteurs

Balwina Koopal (B)

Laboratory of Biochemistry, Wageningen University, 6708, WE, Wageningen, The Netherlands.

Sumanth K Mutte (SK)

Laboratory of Biochemistry, Wageningen University, 6708, WE, Wageningen, The Netherlands.

Daan C Swarts (DC)

Laboratory of Biochemistry, Wageningen University, 6708, WE, Wageningen, The Netherlands. Electronic address: daan.swarts@wur.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH